Cancer Prevention Research Small Grant Program (R03)
The summary for the Cancer Prevention Research Small Grant Program (R03) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Cancer Prevention Research Small Grant Program (R03): The Division of Cancer Prevention of the National Cancer Institute (NCI) invites applications that address developmental research in chemoprevention agent development, biomarkers, early detection, and nutrition science. However, it is important to note that this funding opportunity does not include applications that are focused on treatment, etiology, or treatment-related quality of life studies that are population based. This Small Grants Program is designed to aid and facilitate the growth of a nationwide cohort of scientists with a high level of research expertise in cancer prevention research. It is anticipated that this Small Grant Program may lead to the submission of subsequent individual research project grants (R01).-This Funding Opportunity Announcement (FOA) will utilize the NIH Small (R03) grant mechanism. -The NIH R03 grant mechanism supports different types of projects including: pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. -The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. -Budgets for direct costs of up to $50,000 per year and a project duration of up to 2 years may be requested for a maximum of $100,000 direct costs over a 2-year project period. -Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications; therefore, the anticipated number of awards is not known. -Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. -Eligible organizations include: for-profit organizations; non-profit organizations; public or private institutions, such as universities, colleges, hospitals, and laboratories; units of State governments; units of State Tribal governments; units of local governments; units of local Tribal governments; eligible institutions of the Federal Government; domestic institutions and organizations; foreign institutions and organizations; and faith-based or community-based organizations. - Eligible Project Directors/Principal Investigators (PDs/PIs): Any individual with the skills, knowledge, and resources necessary to carry out the proposed research is invited to work with his/her institution to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. -New, as well as experienced, investigators in relevant fields and disciplines (e.g., chemoprevention, nutritional science, genetics, infectious agents, and early detection, including biomarker development and validation) may apply for small grants to test ideas or do pilot studies. -Applicants may submit more than one application, provided each application is scientifically distinct.
Federal Grant Title: | Cancer Prevention Research Small Grant Program (R03) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Education Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PAR-06-313 |
Type of Funding: | Grant |
CFDA Numbers: | 93.393 |
CFDA Descriptions: | Cancer Cause and Prevention Research |
Current Application Deadline: | No deadline provided |
Original Application Deadline: | Multiple Receipt Dates - See Link to Full Announce |
Posted Date: | Apr 04, 2006 |
Creation Date: | Apr 04, 2006 |
Archive Date: | Jan 20, 2008 |
Total Program Funding: | |
Maximum Federal Grant Award: | $50,000 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education State governments Others (see text field entitled "Additional Information on Eligibility" for clarification) For profit organizations other than small businesses Public and State controlled institutions of higher education County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Independent school districts Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments
- Additional Information on Eligibility
- Foreign institutions are eligible to apply. Eligible agencies of the Federal Government are eligible to apply. Faith-based or community-based organizations.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster - Similar Government Grants
- • Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
- • Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based I...
- • Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Tr...
- • Research Projects to Enhance Applicability of Mammalian Models for Translational Research ...
- • NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optio...
- • Pilot Studies in Pancreatic Cancer
- • Cancer Prevention Research Small Grant Program
- • Molecular Targets for Nutrients in Prostate Cancer Prevention
- More Grants from the National Institutes of Health
- • Laboratories to Optimize Digital Health (R01 Clinical Trial Required)
- • NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdocto...
- • Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinar...
- • NIH SIREN Neurologic Clinical Trials (UG3/UH3 - Clinical Trial Required)
- • Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)